Skip to main content

Vertex Pharmaceuticals Inc

VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000875320

In the last 90 days, Vertex Pharmaceuticals Inc insiders filed 0 open-market purchases and 3 sales; 1,763 institutions reported holding it in 13F filings for Q2 2026, worth $119.7B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vertex Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $2.00M in total
Insiders trading
3
Net value
−$2.00M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vertex Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vertex Pharmaceuticals Inc
NameTitleLast reported holdingLast filingFilings, past year
van Grunsven JasperEVP, CP and NPPO8,682Sep 10, 20261
Ambrose KristenSVP & Chief Accounting Officer11,624Sep 1, 20267
Sachs Bruce IDirector39,000Aug 31, 20266
Tatsis OuraniaEVP, Chief Reg. & Quality Off.53,572Jul 23, 20269
Sachdev AmitEVP Chief Patient & Ext Af Off66,512Jul 23, 20267
Garber Alan MDirector7,344Jul 17, 20263
McKechnie DuncanEVP, Chief Commercial Officer11,001Jul 7, 20268
Liu JoyEVP and Chief Legal Officer19,131Jul 6, 20265
Bozic CarmenEVP and CMO15,337Jun 30, 202615
Bunnage Mark E.EVP, Chief Scientific Officer7,284May 19, 20265
Carney LloydDirector6,315May 5, 20262
Lagarde MichelDirector1,132May 5, 20261
Upadhyay SuketuDirector1,558May 5, 20264
Bhatia Sangeeta N.Director4,924May 5, 20262
McKenzie DianaDirector2,378May 5, 20261
Schneider JenniferDirector1,394May 5, 20261
Thornberry NancyDirector2,109May 5, 20261
Kewalramani ReshmaCEO & President98,278Mar 3, 20266
Wagner Charles F JrEVP, CO & FO47,042Feb 26, 20267
Leiden Jeffrey MExecutive Chairman34,797Feb 26, 20265
Biller JonathanEVP and Chief Legal Officer13,659Feb 26, 20267
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.18,432Feb 26, 20266
Altshuler DavidEVP, Chief Scientific Officer34,477Jan 26, 20261
Arbuckle Stuart AEVP, COO63,368Jul 2, 20250
Kearney Terrence CDirector6,536May 3, 20240
Sanna BastianoEVP, Cell & Genetic Therapies32,038May 9, 20230
McGlynn Margaret GDirector178May 3, 20230
Lee YuchunDirector1,875May 3, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 1, 2023 (view filing)May 302 daysArbuckle Stuart AEVP, COOSSale−82$329.82−$27.0K−0.1%56.6K after10b5-1
Jun 20, 2023 (view filing)Jun 155 daysArbuckle Stuart AEVP, COOSSale−8.60K$349.00−$3.00M−13.2%56.6K after10b5-1
Jul 18, 2023 (view filing)Jul 171 dayKewalramani ReshmaCEO & PresidentSSale−7.83K$355.00−$2.78M−6.2%118.9K after10b5-1
Jul 18, 2023 (view filing)Jul 171 daySachs Bruce IDirectorSSale−11.3K$356.75−$4.01M−22.0%40.0K after3 lots10b5-1
Aug 11, 2023 (view filing)Aug 92 daysBhatia Sangeeta N.DirectorSSale−242$345.51−$83.6K−5.2%4.39K after10b5-1
Aug 11, 2023 (view filing)Aug 92 daysAltshuler DavidEVP, Global Research and CSOSSale−63$345.51−$21.8K−0.2%32.0K after10b5-1
Aug 14, 2023 (view filing)Aug 104 daysSachdev AmitEVP, Chief Patient OfficerSSale−10.0K$350.00−$3.51M−14.6%58.8K after10b5-1
Aug 14, 2023 (view filing)Aug 104 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−5.75K$345.79−$1.99M−10.1%51.1K after10b5-1
Aug 14, 2023 (view filing)Aug 104 daysKearney Terrence CDirectorSSale−10.0K$350.00−$3.50M−60.5%6.54K after10b5-1
Aug 25, 2023 (view filing)Aug 232 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−2.50K$355.00−$887.5K−4.9%48.6K after10b5-1
Sep 7, 2023 (view filing)Sep 52 daysBozic CarmenEVP and CMOSSale−5.65K$352.66−$1.99M−8.9%57.6K after10b5-1
Sep 21, 2023 (view filing)Sep 192 daysBozic CarmenEVP and CMOSSale−5.65K$351.00−$1.98M−9.8%51.9K after10b5-1
Oct 3, 2023 (view filing)Oct 21 dayBiller JonathanEVP and Chief Legal OfficerSSale−610$346.76−$211.5K−5.5%10.6K after10b5-1
Oct 5, 2023 (view filing)Oct 32 daysBozic CarmenEVP and CMOSSale−5.65K$345.28−$1.95M−10.9%46.3K after10b5-1
Oct 11, 2023 (view filing)Oct 65 daysBhatia Sangeeta N.DirectorSSale−242$360.00−$87.1K−5.5%4.14K after10b5-1
Oct 18, 2023 (view filing)Oct 162 daysLeiden Jeffrey MExecutive ChairmanSSale−13.0K$374.00−$4.85M−36.6%22.4K after10b5-1
Oct 19, 2023 (view filing)Oct 172 daysBhatia Sangeeta N.DirectorSSale−243$375.00−$91.1K−5.9%3.90K after10b5-1
Oct 19, 2023 (view filing)Oct 172 daysBozic CarmenEVP and CMOSSale−5.65K$373.25−$2.11M−12.2%40.6K after10b5-1
Nov 2, 2023 (view filing)Oct 312 daysBozic CarmenEVP and CMOSSale−5.65K$355.92−$2.01M−13.9%35.0K after10b5-1
Nov 8, 2023 (view filing)Nov 62 daysSachs Bruce IDirectorSSale−11.3K$385.00−$4.33M−22.0%40.0K after10b5-1
Nov 15, 2023 (view filing)Nov 132 daysKewalramani ReshmaCEO & PresidentSSale−5.10K$377.00−$1.92M−4.3%113.8K after10b5-1
Nov 16, 2023 (view filing)Nov 142 daysBozic CarmenEVP and CMOSSale−5.65K$380.82−$2.15M−16.2%29.3K after10b5-1
Nov 17, 2023 (view filing)Nov 152 daysAltshuler DavidEVP, Global Research and CSOSSale−19$369.92−$7.03K−0.1%32.0K after10b5-1
Nov 17, 2023 (view filing)Nov 152 daysSachdev AmitEVP Chief Patient & Ext Af OffSSale−35$369.92−$12.9K−0.1%58.8K after10b5-1
Nov 21, 2023 (view filing)Nov 201 dayWagner Charles F JrEVP & Chief Financial OfficerSSale−3.00K$349.88−$1.05M−6.0%46.7K after10b5-1
Dec 15, 2023 (view filing)Dec 132 daysArbuckle Stuart AEVP, COOSSale−8.60K$399.00−$3.43M−13.2%56.6K after10b5-1
Dec 15, 2023 (view filing)Dec 132 daysKewalramani ReshmaCEO & PresidentSSale−5.10K$397.00−$2.02M−4.5%108.7K after10b5-1
Dec 15, 2023 (view filing)Dec 132 daysLeiden Jeffrey MExecutive ChairmanSSale−13.4K$399.42−$5.33M−59.5%9.07K after2 lots10b5-1
Dec 19, 2023 (view filing)Dec 154 daysKewalramani ReshmaCEO & PresidentSSale−17.1K$407.00−$6.97M−13.6%108.7K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysWagner Charles F JrEVP & Chief Financial OfficerSSale−3.00K$405.00−$1.22M−6.4%43.7K after10b5-1
Jan 10, 2024 (view filing)Jan 82 daysLeiden Jeffrey MExecutive ChairmanSSale−6.65K$419.07−$2.79M−73.3%2.42K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayAltshuler DavidEVP, Global Research and CSOSSale−3.15K$420.24−$1.32M−6.2%47.6K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayAmbrose KristenSVP & Chief Accounting OfficerSSale−1.37K$420.24−$577.4K−12.4%9.68K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayArbuckle Stuart AEVP, COOSSale−4.29K$420.24−$1.80M−5.4%75.7K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−913$420.24−$383.7K−3.8%23.1K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayBiller JonathanEVP and Chief Legal OfficerSSale−1.74K$418.77−$727.8K−8.7%18.3K after10b5-1
Feb 13, 2024 (view filing)Feb 121 daySachdev AmitEVP Chief Patient & Ext Af OffSSale−3.22K$420.24−$1.35M−4.2%74.4K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−314$420.24−$132.0K−0.5%68.2K after10b5-1
Feb 14, 2024 (view filing)Feb 12-132 daysLeiden Jeffrey MExecutive ChairmanSSale−3.39K$419.42−$1.42M−11.2%26.9K after3 lots10b5-1
Feb 16, 2024 (view filing)Feb 14-152 daysLeiden Jeffrey MExecutive ChairmanSSale−9.01K$419.10−$3.78M−33.5%17.9K after2 lots10b5-1
Feb 21, 2024 (view filing)Feb 201 dayAltshuler DavidEVP, Global Research and CSOSSale−4.00K$420.79−$1.68M−9.8%37.0K after10b5-1
Feb 21, 2024 (view filing)Feb 201 dayArbuckle Stuart AEVP, COOSSale−4.80K$420.79−$2.02M−7.1%63.0K after10b5-1
Feb 21, 2024 (view filing)Feb 201 dayAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−801$420.79−$337.1K−3.9%19.7K after10b5-1
Feb 21, 2024 (view filing)Feb 201 daySachdev AmitEVP Chief Patient & Ext Af OffSSale−4.25K$420.79−$1.79M−6.2%64.0K after10b5-1
Feb 21, 2024 (view filing)Feb 201 dayTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−480$420.79−$202.0K−0.8%59.8K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysAltshuler DavidEVP, Global Research and CSOSSale−3.00K$421.77−$1.27M−8.1%34.0K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysArbuckle Stuart AEVP, COOSSale−3.60K$421.77−$1.52M−5.7%59.4K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−1.20K$421.77−$506.5K−6.1%18.5K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysSachdev AmitEVP Chief Patient & Ext Af OffSSale−3.19K$421.77−$1.35M−5.0%60.8K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−360$421.77−$151.8K−0.6%59.5K after10b5-1